Back to mobile site

Jefferies Reiterates Buy on Magellan Health (MGLN) Following 4Q - PT to $77

March 1, 2016 9:35 AM EST Send to a Friend
Jefferies reiterated a Buy rating on Magellan Health Services (NASDAQ: MGLN), and raised the price target to $77.00 (from $73.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login